AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimfirst-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimfirst-M 1 Tablet PR

DiaBetaDuo, a single-dose tablet, is an antidiabetic medication combining two active agents for adult-onset type 2 diabetes management. It effectively regulates blood glucose. DiaBetaDuo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic effect. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. DiaBetaDuo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are recommended.

Uses of Glimfirst-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimfirst-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Glimfirst-M 1 Tablet PR with a meal.

Common Side effects of Glimfirst-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimfirst-M 1 Tablet PR:

Follow your doctor's instructions or consult the product label for proper usage. Take one Glimfirst-M PR tablet with a meal.

How Glimfirst-M 1 Tablet PR works:

Glimfirst-M PR, a single-dose tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimfirst-M 1 Tablet PR is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimfirst-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

The use of Glimfirst-M 1 Tablet PR is contraindicated while breastfeeding due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimfirst-M 1 Tablet PR cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimfirst-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced starting dose is generally advised for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimfirst-M 1 Tablet PR :

Should you forget a dose of your Glimfirst-M 1 Tablet PR medication, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimfirst-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimfirst-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely, ensuring it's inaccessible to children, pets, and others.
Glimfirst-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimfirst-M 1 Tablet PR and seek immediate medical attention.
Glimfirst-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for treating type 1 DM.
Glimfirst-M 1 Tablet PR may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimfirst-M 1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimfirst-M 1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimfirst-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimfirst-M 1 Tablet PR
66
MRP 80
17% off